PEOPLE - Spectranetics (US) makes appointments:
This article was originally published in Clinica
Spectranetics, a US company which develops technology for interventional cardiovascular therapy, has appointed Paul Samek vice-president for finance and chief financial officer. Spectranetics controller Guy Childs who has been acting CFO, is promoted to director of finance. He reports to Mr Samek, who joins from the Nash Engineering Company.
You may also be interested in...
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.